Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia

PURPOSE: The decision to re-induce patients with acute myeloid leukemia (AML) based on results of the day 14 bone marrow (BM) biopsy is variable and lacks evidence based data. The aim of our review was to evaluate the accuracy of a day 14 BM biopsy in determining the need for re-induction chemothera...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Morris, Tod A., DeCastro, Carlos M., Diehl, Louis F., Gockerman, Jon P., Lagoo, Anand S., Li, Zhiguo, Moore, Joseph O., Rizzieri, David A., Rao, Arati V.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3753071/
https://ncbi.nlm.nih.gov/pubmed/23046833
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2012.09.016
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky